Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma

M Montesinos-Rongen, E Godlewska, A Brunn… - Acta …, 2011 - Springer
Primary central nervous system lymphoma (PCNSL) is a special lymphoma entity. Although
being a rare disease, the incidence of PCNSL has significantly raised in the last decades [3, …

Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis

K Drögemüller, U Helmuth, A Brunn… - The Journal of …, 2008 - journals.aai.org
Toxoplasma gondii infects astrocytes, neurons and microglia cells in the CNS and, after
acute encephalitis, persists within neurons. Robust astrocyte activation is a hallmark of …

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression

…, M Kocher, G Ceccon, JM Werner, A Brunn… - Neuro …, 2020 - academic.oup.com
The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted therapy
(TT) has dramatically improved the prognosis of various cancer types. However, following …

Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation

…, K Drögemüller, U Händel, A Brunn… - The Journal of …, 2011 - journals.aai.org
Astrocytes are activated in experimental autoimmune encephalomyelitis (EAE) and have
been suggested to either aggravate or ameliorate EAE. However, the mechanisms leading to …

Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphoma

M Montesinos-Rongen, R Schmitz, A Brunn… - Acta …, 2010 - Springer
Primary CNS lymphoma (PCNSL), the intracerebral subgroup of diffuse large B cell lymphoma
(DLBCL), shows evidence for aberrant activation of the nuclear factor (NF)-κB pathway. In …

Diagnosis of leptomeningeal disease in diffuse large B‐cell lymphomas of the central nervous system by flow cytometry and cytopathology

…, C Heute, M Vorgerd, A Brunn… - European journal of …, 2010 - Wiley Online Library
Reliable detection of leptomeningeal disease has the potential of facilitating the diagnosis
of central nervous system (CNS) lymphoma and is important for therapeutic considerations. …

Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma

RT Ullrich, L Kracht, A Brunn, K Herholz… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Methyl-l- 11 C-methionine ( 11 C-MET) PET has been shown to detect brain tumors with a
high sensitivity and specificity. In this study, we investigated the potential of 11 C-MET PET to …

Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup …

A Brunn, I Nagel, M Montesinos-Rongen… - Acta …, 2013 - Springer
IHC applying cut-off levels similar to Horn et al.[3] identified 82%(41/50) of pCNsL as
MYChighBCL2high and 90%(45/50) as MYChighBCL2high or MYChighBCL6high De. 70%(35/50) …

Primary lymphoma of the central nervous system—a diagnostic challenge

M Deckert, A Brunn… - Hematological …, 2014 - Wiley Online Library
Primary lymphoma of the central nervous system is a distinct diffuse large B‐cell lymphoma
confined to the nervous system. Whereas classical cases can be classified easily, differential …

Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice

M Deckert, M Montesinos-Rongen, A Brunn… - Acta …, 2014 - Springer
Primary lymphoma of the central nervous system (CNS, PCNSL) is a specific diffuse large B
cell lymphoma entity arising in and confined to the CNS. Despite extensive research since …